BCL2L1 and breast carcinoma: 2'-OMe-PS modified Bcl-xSSOs caused a splice shift from Bcl-xL to Bcl-xS and increased apoptosis of prostate cancer, breast cancer, and hepatic stellate cells [97, 147].